Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):366-75

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):366-75

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Functional imaging in pre-motor Parkinson’s disease

Arnaldi D. 1, Morbelli S. 2, Picco A. 1, Ferrara M. 1, Buschiazzo A. 2, Famà F. 1, De Carli F. 3, Nobili F. 1

1 Unit of Clinical Neurology, Department of Neuroscience (DINOGMI), University of Genoa, IRCCS AOU San Martino‑IST, Genoa, Italy; 2 Nuclear Medicine Department of Health Sciences (DISSAL), University of Genoa, IRCCS AOU San Martino‑IST, Genoa, Italy; 3 Institute of Molecular Bioimaging and Physiology, National Research Council, Genoa, Italy


PDF  


Several non motor symptoms (NMS) can precede the onset of the classical motor Parkinson’s disease (PD) syndrome. The existence of pre-motor and even pre-clinical PD stages has been proposed but the best target population to be screened to disclose PD patients in a pre-clinical, thus asymptomatic, stage is still matter of debate. The REM sleep behavior disorder (RBD) often affects PD patients at different stages of the disease and could precede the onset of motor symptoms by several years. However, RBD could also precede other synucleinopathies (namely, dementia with Lewy bodies and multisystem atrophy), and less frequently could be related to other neurological conditions or remain idiopathic. Moreover, not all PD patients exhibit RBD. Despite these caveats, RBD probably represents the best feature to disclose pre-motor PD patients given its high-risk of developing a full motor syndrome. Other clinical clues in the premotor stages of PD undergoing active investigation include hyposmia, depression, and autonomic dysfunction. Effective biomarkers are needed in order to improve the diagnostic accuracy in the pre-motor stage of PD, to monitor disease progression and to plan both pharmacological and non-pharmacological intervention. Functional imaging, in particular radionuclide methodologies, has been often used to investigate dopaminergic and non-dopaminergic features as well as cortical functioning in patients with RBD in its idiopathic form (iRBD) and/or associated with PD. Recently, new tracers to image α-synuclein pathologies are under development. Functional imaging in pre-motor PD, and in particular in iRBD, could improve our knowledge about the underlying mechanisms and the neurodegenerative progress of PD.

top of page

Publication History

Cite this article as

Corresponding author e-mail

dario.arnaldi@gmail.com.